TL;DR
This study reveals that tauroursodeoxycholic acid (TUDCA), a bile acid derivative, significantly improves intestinal barrier function in weaned piglets by modulating the TGR5-MLCK pathway. This improvement is linked to changes in gut bacteria and serum metabolites, suggesting TUDCA's potential as a dietary supplement to enhance gut health in piglet production.
What Problem Does This Paper Address?
Weaning is a critical and stressful period for piglets, often leading to gastrointestinal issues like diarrhea, reduced immunity, and impaired growth. This is partly due to an immature digestive system and the challenges of adapting to a new diet and environment. While bile acids are known to aid digestion, their specific role in modulating the intestinal barrier function during this vulnerable stage, particularly in piglets, has been unclear. This paper investigates whether TUDCA, a well-known bile acid with potential therapeutic benefits, can mitigate these weaning-related intestinal problems and elucidate the underlying molecular mechanisms.
Methods
The researchers employed a multi-pronged approach combining in vivo and in vitro studies.
- In vivo (Piglet Study): 72 healthy weaned piglets were divided into two groups: a control group fed a basal diet and a TUDCA group fed the basal diet supplemented with 200 mg/kg TUDCA for 30 days. The study monitored growth performance, diarrhea incidence, intestinal morphology (villus height, crypt depth, goblet cell count), tight junction protein expression (ZO-1, OCC, Claudin-1), serum markers of intestinal permeability (LPS, DAO), and immune indices (IgG, sIgA, inflammatory cytokines). Additionally, serum metabolic profiles were analyzed using UPLC-MS/MS, and gut microbiota composition was assessed via 16S rRNA gene sequencing.
- In vitro (Cell Culture Study): Porcine intestinal epithelial cells (IPEC-J2) were used to investigate the molecular mechanisms. Cells were treated with TUDCA and/or E. coli (a common pathogen) to mimic E. coli-induced intestinal barrier impairment. Further experiments involved silencing the TGR5 gene (using siRNA) and inhibiting the MLCK pathway (using ML-7) to determine their roles in TUDCA's protective effects. Protein expression of tight junction proteins, TGR5, and components of the TGR5-MLCK pathway were analyzed using Western blotting. Intracellular cAMP levels were also measured.
Datasets
- Piglet Growth and Health Data: Collected from 72 weaned piglets over a 30-day period, including body weight, feed intake, diarrhea incidence, and fecal consistency.
- Intestinal Tissue Samples: Jejunal and ileal sections from selected piglets were used for histological analysis (H&E, PAS staining) and molecular analysis (Western blotting).
- Serum Samples: Collected from piglets for metabolic profiling (UPLC-MS/MS) and analysis of immune and permeability markers (ELISA).
- Fecal Samples: Collected from piglets for 16S rRNA gene sequencing to assess gut microbiota composition.
- IPEC-J2 Cell Culture Data: Generated from in vitro experiments involving treatments with TUDCA, E. coli, TGR5 siRNA, and ML-7, analyzed for protein expression and cellular responses.
Key Insights and Ideas
- TUDCA as a Gut Protector: The study strongly suggests TUDCA is not just for liver health but also a potent agent for improving intestinal barrier function, particularly in the vulnerable post-weaning period.
- Beyond Growth Performance: While TUDCA didn't significantly boost overall growth metrics (weight gain, feed intake), its impact on reducing diarrhea incidence is a crucial finding for animal health and welfare.
- The TGR5-MLCK Axis: The identification of the TGR5-MLCK pathway as a key mediator of TUDCA's protective effects is a significant mechanistic insight. TUDCA appears to activate TGR5, which in turn suppresses the E. coli-induced activation of MLCK, ultimately stabilizing tight junctions.
- Gut Microbiota and Metabolome Interplay: TUDCA's ability to alter both the composition of gut bacteria (increasing beneficial genera like Parabacteroides and Mucispirillum, and decreasing harmful ones like Streptococcus) and the profile of serum metabolites highlights a complex, interconnected system that TUDCA influences.
- Tryptophan Metabolism Link: The observed changes in tryptophan metabolites, which are known to play a role in maintaining intestinal integrity, suggest a novel mechanism by which TUDCA might indirectly support gut health.
Key Results
- Reduced Diarrhea: TUDCA supplementation significantly reduced the incidence of diarrhea in weaned piglets (P < 0.005).
- Improved Intestinal Morphology: TUDCA increased villus height-to-crypt depth ratios and the number of goblet cells in the jejunum and ileum.
- Enhanced Barrier Integrity: TUDCA increased the expression of tight junction proteins (ZO-1, OCC, Claudin-1) and decreased serum levels of LPS and DAO, indicating a stronger intestinal barrier.
- Immune Modulation: TUDCA increased serum IgG and ileal sIgA levels while reducing pro-inflammatory cytokines (IL-1β, NF-κB) and increasing anti-inflammatory cytokines (IL-4, IL-10).
- Microbiota Shifts: TUDCA increased the relative abundance of Parabacteroides and Mucispirillum and decreased Streptococcus and Treponema 2 at the genus level.
- Metabolomic Changes: TUDCA altered serum metabolic profiles, with notable changes in tryptophan metabolites.
- In vitro Validation: TUDCA reversed E. coli-induced decreases in tight junction proteins and increased TGR5 expression in IPEC-J2 cells. Knockdown of TGR5 abolished these protective effects, and TUDCA's ability to suppress MLCK activation was TGR5-dependent.
Limitations and Future Work
The authors acknowledge that while TUDCA improved intestinal barrier function and reduced diarrhea, it did not significantly impact overall growth performance (final body weight, ADG, ADFI, F/G). This suggests that while gut health is improved, other factors might be limiting growth in this specific experimental setup.
Future work could focus on:
- Investigating the precise mechanisms by which TUDCA influences tryptophan metabolism and its downstream effects on the intestinal barrier.
- Exploring the long-term effects of TUDCA supplementation on piglet health and performance.
- Determining optimal TUDCA dosages and administration methods for different piglet production systems.
- Further elucidating the role of TGR5 in mediating TUDCA's anti-inflammatory effects beyond the gut.
Summary updated